Latest Enzymes News

Steirischer Kren macht aktive Enzyme sichtbarBiokatalysatoren kommen immer öfter beim Herstellen von Pharmazeutika zum Einsatz. Das Austrian Centre of Industrial Biotechnology forscht an der Herstellung von Transaminasen im großen Stil und kann deren Aktivität mit einem neuen Testverfahren s...

Researchers create rewritable biological data storage systemResearchers at Stanford University have created a biologic storage system composed of two enzymes that splice DNA sequences f -More-

Gene therapy can effectively treat ADA-deficient severe combined immunodeficiencySevere combined immunodeficiency is defect in the immune system that results in a loss of the adaptive immune cells known as B cells and T cells. Mutations in several different genes can lead to the development of severe combined immunodeficiency, in...

Why People Stick with Cancer Screening, Even When It Causes HarmThe data on PSA testing to detect prostate cancer has long been shaky -- so much so that the discoverer of PSA (or prostate-specific antigen, an enzyme made by the prostate) himself decried the test two years ago as "hardly more effective than a coin...

A high‐throughput assay for enzymatic polyester hydrolysis activity by fluorimetric detectionA fluorimetric assay for the fast determination of the activity of polyester‐hydrolyzing enzymes in a large number of samples has been developed. Terephthalic acid is a main product of the enzymatic hydrolysis of polyethylene terephthalate, a synth...

New method developed to synthesise a set of potential glycosidase inhibitorsIn many biological and pathological processes, glycosidase enzymes attack glycosidic bonds in carbohydrates, glycoproteins, and glycolipids. The ability to modify or block these processes by specific glycosidase inhibitors forms the basis for their p...

Simple, Quantitative Sensitive High-throughput Antibody Detection for Lyme DiseaseThis technology is for compositions and methods for diagnosis of Lyme disease. Currently, Lyme disease is diagnosed by clinical exam and a history of exposure to endemic regions. Although, laboratory tests may aid diagnosis, the best tests currently available are slow and labor intensive and require understanding of the test, and infection stage. A two-step antibody based test process is currently...

Cryptic peroxisomal targeting via alternative splicing and stop codon read-through in fungiPeroxisomes are eukaryotic organelles important for the metabolism of long-chain fatty acids. Here we show that in numerous fungal species, several core enzymes of glycolysis, including glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 3-phosphogl...

Gilead Files European Marketing Application for Boosting Agent CobicistatGilead Sciences, Inc. (Nasdaq: GILD) announced today that the Marketing Authorisation Application (MAA) for cobicistat, submitted on April 26, 2012, has been validated by the European Medicines Agency (EMA). Cobicistat is Gilead’s pharmacoenhancing or “boosting” agent that increases blood levels of certain commercially available protease inhibitors,...

Dr. Bob Sears Shares “What to Expect” as a New ParentDr. Bob Sears is a renowned pediatrician, and contributing author in the Sears Parenting Library. But the children’s health expert has one job that trumps them all: Dad. As the father of three, Dr. Sears has spent the better part of two decades providing medical care to children, both in his office and at home. In line with the release of the blockbuster...

Jarrow Formulas Launches Phosphomega, an All-New Bioavailable Phospholipid-Bound Omega-3 SupplementPhosphOmega, an Omega-3 Fish Oil Nutritional Supplement, is responsibly sourced and thoroughly tested to ensure purity Los Angeles, CA (PRWEB) May 23, 2012 Jarrow Formulas®, a formulator and supplier of superior nutritional health supplements, announces the launch of PhosphOmega®, a naturally bound phospholipid-omega-3 fatty acid complex. Phospholipid-bound omega-3s have higher bioavail...

Codexis strengthens relationship with Merck & CoIndustrial enzyme developer Codexis has had its supply contract extended by Merck & Co and been granted key patents for its Hep-C enzymes.

Leader in Antibacterial Phage Technology Micreos Secures Growth CapitalWAGENINGEN, The Netherlands, May 23, 2012 /PRNewswire/ -- Micreos of The Netherlands has attracted additional capital for accelerated growth of its phage business. Altria Ventures, the strategic investment arm of Altria Group, has acquired a5% stake in Micreos, viewed as global leader in phage technology for targeted control of bacteria. Phage technology is set to change the world, because it is...

Enzyme Adapted to Enhance Nerve Agent Detoxification CapacityResearchers have used directed evolution of a human liver enzyme to enhance its capacity to detoxify the most threatening...

Codexis extends agreement with Merck and CoMerck will continue to use Codexis enzymes in pharmaceutical manufacturing processes

Codexis extends collaboration with Merck to 2015Redwood City, Calif.-based Codexis, a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals and pharmaceuticals, has extended its catalyst and process development collaboration with Merck to develop enzymes for us...

Pure Green Coffee Bean Extract Changes Weight Loss Supplement Industry After Scientific Results Exposed by Dr OzDr Oz's pure green coffee bean extract TV episode sparked a loud debate over the legitimacy for natural weight loss using green coffee beans. Find out the Pure Green Coffee Extract results exposed by Doctor Oz as millions looked on. Los Angeles, CA (PRWEB) May 23, 2012 As summer quickly approaches and the sun continues to shine longer, finding a premium natural weight loss supplement such as...

Codexis extends process development collaboration with MerckCodexis has extended its catalyst and process development collaboration with Merck for three years to develop enzymes for use in pharmaceutical manufacturing.

Epizyme Builds A Cancer Company At Mach SpeedEpizyme’s recent alliance with Celgene validates industry’s interest in histone methyltransferase inhibitors, a kinase-like class of epigenetic enzymes. Celgene’s willingness to cede US rights in return for access to preclinical assets belies H...

MethylGene to Present at BioFinance 2012 Conference MONTREAL, CANADA -- (Marketwire) -- 05/23/12 -- MethylGene Inc. (TSX: MYG) today announced that Mr. Joseph Walewicz, Vice President, Business and Corporate Development, will present an overview of the Company at the BioFinance 2012 Conference which will be held at the St. Andrew's Club & Conference Centre in Toronto. Mr. Walewicz will be presenting on Wednesday, May 30 at 9:20 a.m. BioFinan...

IBEX Reports Update on JF Gareau/Garvinci Lawsuit MONTREAL, QUEBEC -- (Marketwire) -- 05/23/12 -- IBEX Technologies Inc. (TSX VENTURE: IBT) today reported on the progress of its action against JF Gareau and Garvinci Inc. BACKGROUND During the period from May 2006 to April 2007, IBEX (as part of a proposed transaction) made a series of loans to Garvinci Inc. totaling $1,000,000. These loans were personally guaranteed by JF Gareau, the principa...

Codexis Announces Three-Year Extension of Collaboration Agreement with MerckCodexis, Inc. (NASDAQ:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals and pharmaceuticals, today announced a three-year extension of its catalyst and process development collaboration with Merck to develop enzymes for use in pharmaceutical manufacturing. As the collaboration enters its sixth year...

IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair ResearchNEW YORK, May 22, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (OTCQB: SVFC.PK) announced today that it has entered a sponsored research agreement with the Institute for Cell Engineering and Regenerative Medicine (ICERM) at the University of Florida. A portion of the collaborative work will be to explore the physiological characteristics o...

Massage Envy Spa® Announces One Millionth FacialSCOTTSDALE, Ariz., May 22, 2012 /PRNewswire/ -- Massage Envy, the pioneer and national leader of professional, convenient and affordable massage and spa services announced today that the company has performed its one-millionth facial. The recipient of the Anti-Aging Facial was Harriet Haun, a member at the Massage Envy Spa located at 3100 Texas Sage Trail in the Alliance Town Center in Fort W...

Plant Flavonoids May Yield a New Generation of Drugs to Prevent Blood ClotsChemical compounds that block the activity of the enzyme protein disulfide isomerase are being considered for development into...

0 1 2 3 4 ›»

buy Enzymes market research data and corporate reports now Advertisement